- Home
- WF vs ASND Comparison
WF vs ASND Comparison
Compare WF & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WF | ASND |
|---|---|---|
| Founded | 1899 | 2006 |
| Country | South Korea | Denmark |
| Employees | N/A | 1189 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 17.1B |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WF | ASND |
|---|---|---|
| Price | $70.04 | $267.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $304.82 |
| AVG Volume (30 Days) | 86.0K | ★ 607.1K |
| Earning Date | 10-23-2026 | 11-12-2026 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.08 | $89.94 |
| Revenue Next Year | $5.18 | $46.86 |
| P/E Ratio | $9.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $48.83 | $188.08 |
| 52 Week High | $84.71 | $282.15 |
Technical Indicators
Market Signals| Indicator | WF | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 70.55 |
| Support Level | $68.52 | $216.52 |
| Resistance Level | $71.82 | $272.47 |
| Average True Range (ATR) | 1.66 | 6.24 |
| MACD | 0.55 | 1.74 |
| Stochastic Oscillator | 75.52 | 91.77 |
Price Performance
Historical ComparisonAbout WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of businesses, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, life insurance, and other businesses. It provides products and services to customers, which mainly comprise small- and medium-sized enterprises and individuals, as well as some of Korea's corporations. It has six operational business segments: banking, life insurance, credit card, capital, investment securities, and other operations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.